X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-04-30 | ZNTL | Myers Scott Dunseth | Dir | P - Purchase | $1.40 | +21,000 | 281,192 | +8% | +$29,373 | ||||||
2025-02-06 | ZNTL | Bruns Ingmar | Chief Medical Officer | P - Purchase | $2.28 | +20,000 | 36,629 | +120% | +$45,656 | ||||||
| D | 2025-02-03 | ZNTL | Vultaggio Vincent | PAO, Interim PFO | S - Sale+OE | $1.71 | -2,615 | 189,826 | -1% | -$4,476 | |||||
| D | 2025-02-03 | ZNTL | Lackner Mark | Chief Scientific Officer | S - Sale+OE | $1.71 | -14,368 | 512,856 | -3% | -$24,591 | |||||
| D | 2025-02-03 | ZNTL | Paul Andrea | GC | S - Sale+OE | $1.71 | -13,230 | 1,070,784 | -1% | -$22,643 | |||||
2025-01-31 | ZNTL | Skvarka Jan | Dir | P - Purchase | $1.72 | +60,000 | 149,551 | +67% | +$103,446 | ||||||
2025-01-31 | ZNTL | Walker Luke Nathaniel | Dir | P - Purchase | $1.76 | +14,200 | 86,681 | +20% | +$24,966 | ||||||
2025-01-31 | ZNTL | Eastland Julia Marie | CEO, Pres | P - Purchase | $1.73 | +28,500 | 28,500 | New | +$49,345 | ||||||
2025-01-02 | ZNTL | Lackner Mark | Chief Scientific Officer | S - Sale | $3.12 | -4,411 | 191,317 | -2% | -$13,762 | ||||||
2024-10-04 | ZNTL | Vultaggio Vincent | Principal Accounting Officer | S - Sale | $3.18 | -1,603 | 33,855 | -5% | -$5,098 | ||||||
2024-05-31 | ZNTL | Gallagher Cam | Pres, Interim CFO | S - Sale | $11.98 | -9,597 | 633,680 | -1% | -$114,972 | ||||||
2024-05-09 | ZNTL | Hausman Diana | Chief Medical Officer | S - Sale | $12.62 | -3,356 | 373,876 | -1% | -$42,353 | ||||||
2024-02-12 | ZNTL | Epperly Melissa B, | CFO | S - Sale | $11.44 | -2,573 | 451,449 | -1% | -$29,435 | ||||||
2024-02-12 | ZNTL | Gallagher Cam | Pres | S - Sale | $11.44 | -1,173 | 643,277 | 0% | -$13,419 | ||||||
| D | 2024-02-02 | ZNTL | Lackner Mark | Chief Scientific Officer | S - Sale+OE | $11.54 | -1,585 | 195,728 | -1% | -$18,291 | |||||
| D | 2024-02-02 | ZNTL | Paul Andrea | GC | S - Sale+OE | $11.54 | -3,310 | 149,973 | -2% | -$38,197 | |||||
| D | 2024-02-02 | ZNTL | Gallagher Cam | Pres | S - Sale+OE | $11.54 | -11,552 | 644,450 | -2% | -$133,310 | |||||
| D | 2024-02-02 | ZNTL | Epperly Melissa B, | CFO | S - Sale+OE | $11.54 | -8,669 | 454,022 | -2% | -$100,040 | |||||
2023-11-10 | ZNTL | Johnson David Michael | Dir | P - Purchase | $9.88 | +17,000 | 144,389 | +13% | +$167,943 | ||||||
2023-11-13 | ZNTL | Blackwell Kimberly | CEO | P - Purchase | $10.29 | +5,000 | 254,800 | +2% | +$51,448 | ||||||
2023-10-04 | ZNTL | Brownstein Carrie | Chief Medical Officer | S - Sale | $19.50 | -10,628 | 105,685 | -9% | -$207,298 | ||||||
2023-10-04 | ZNTL | Bunker Kevin D. | Chief Scientific Officer | S - Sale | $19.50 | -6,068 | 874,439 | -1% | -$118,355 | ||||||
2023-10-04 | ZNTL | Epperly Melissa B, | CFO | S - Sale | $19.50 | -5,482 | 387,691 | -1% | -$106,926 | ||||||
2023-09-11 | ZNTL | Skvarka Jan | Dir | S - Sale | $25.05 | -5,000 | 47,970 | -9% | -$125,238 | ||||||
2023-06-20 | ZNTL | Matrix Capital Management Company, LP | 10% | P - Purchase | $22.66 | +4,760,000 | 13,959,973 | +52% | +$107,861,600 | ||||||
2023-05-31 | ZNTL | Gallagher Cam | Pres | S - Sale | $26.27 | -27,768 | 463,502 | -6% | -$729,506 | ||||||
2023-05-26 | ZNTL | Bunker Kevin D. | Chief Scientific Officer | S - Sale | $30.02 | -80,000 | 880,507 | -8% | -$2,401,248 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |